Citations

Showing 10 of 108094 citations.

Prediction of measured GFR after living kidney donation from pre-donation parameters
Londen, Marco van , Weijden, Jessica van der , Niznik, Robert S. , Bakker, Stephan J. L. , Berger, Stefan P. , Nolte, Ilja M. , Sanders, Jan‐Stephan , Navis, Gerjan , Borst, Martin H. de , van Londen, Marco , van der Weijden, Jessica , Navis, Gerjan , de Borst, Martin H , Mullan, Aidan F. , Rule, Andrew D.

Mayo Clinic

Nephrology Dialysis Transplantation | June 22, 2022 | Volume: 38 | Issue: 1 | Pages: 212-221

10.1093/ndt/gfac202 | PMID 35731584 Get It

ABSTRACT Background One of the challenges in living kidney donor screening is to estimate remaining kidney function after donation. Here we developed a new model to predict post-donation measured glomerular filtration rate (mGFR) from pre-donation serum creatinine, age and sex. Methods In the prospective development cohort (TransplantLines, n = 511), several prediction models were constructed and tested for accuracy, precision and predictive capacity for short- and long-term post-donation 125I-iothalamate mGFR. The model with optimal performance was further tested in specific high-risk subgroups (pre-donation eGFR <90 mL/min/1.73 m2, a declining 5-year post-donation mGFR slope or age >65 years) and validated in internal (n = 509) and external (Mayo Clinic, n = 1087) cohorts. Results In the development cohort, pre-donation estimated GFR (eGFR) was 86 ± 14 mL/min/1.73 m2 and post-donation mGFR was 64 ± 11 mL/min/1.73 m2. Donors with a pre-donation eGFR ≥90 mL/min/1.73 m2 (present in 43%) had a mean post-donation mGFR of 69 ± 10 mL/min/1.73 m2 and 5% of these donors reached an mGFR <55 mL/min/1.73 m2. A model using pre-donation serum creatinine, age and sex performed optimally, predicting mGFR with good accuracy (mean bias 2.56 mL/min/1.73 m2, R2 = 0.29, root mean square error = 11.61) and precision [bias interquartile range (IQR) 14 mL/min/1.73 m2] in the external validation cohort. This model also performed well in donors with pre-donation eGFR <90 mL/min/1.73 m2 [bias 0.35 mL/min/1.73 m2 (IQR 10)], in donors with a negative post-donation mGFR slope [bias 4.75 mL/min/1.73 m2 (IQR 13)] and in donors >65 years of age [bias 0.003 mL/min/1.73 m2 (IQR 9)]. Conclusions We developed a novel post-donation mGFR prediction model based on pre-donation serum creatinine, age and sex.
The Human Acellular Vessel for Vascular Reconstruction or Bypass
Lauria, Alexis L. , Sen, Indrani , Rasmussen, Todd E.

Mayo Clinic

JAMA Surgery | June 22, 2022 | Volume: 157 | Issue: 8 | Pages: 731

10.1001/jamasurg.2022.1214 | PMID 35731527 Get It

Non-Neoplastic Diseases of the Liver
Kakar, Sanjay , Washington, Kay, Torbenson, Michael , Kakar, Sanjay

Mayo Clinic

No container title available | June 22, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.55418/9781933477183 Get It

Editorial Comment: MRI Is Strengthening the Practice for Pancreatic Cancer Imaging
Bolan, Candice W.

Mayo Clinic

American Journal of Roentgenology | June 22, 2022 | Volume: 219 | Issue: 5 | Pages: 772-772

10.2214/ajr.22.28093 | PMID 35731104 Get It

Diagnostic Performance in Low- and High-Contrast Tasks of an Image-Based Denoising Algorithm Applied to Radiation Dose–Reduced Multiphase Abdominal CT Examinations
Voß, Benjamin, Lee, Nam Ju, Takahashi, Hiroaki , Kozaka, Kazuto , Heiken, Jay P. , Ehman, Eric C. , Vasconcelos, Rogerio N., Fidler, Jeff L. , Lee, Yong S. , Mileto, Achille , Johnson, Matthew P. , Baer‐Beck, Matthias, Weber, Nikkole M. , Michalak, Gregory J. , Halaweish, Ahmed F., Carter, Rickey E. , Inoue, Akitoshi , Voss, Benjamin A, Vasconcelos, Rogerio, Halaweish, Ahmed, Carter, Rickey E , Takahashi, Hiroaki , Lee, Nam Ju, Fidler, Jeff L. , McCollough, Cynthia H. , Fletcher, Joel G.

Mayo Clinic

American Journal of Roentgenology | June 22, 2022 | Volume: 220 | Issue: 1 | Pages: 73-85

10.2214/ajr.22.27806 | PMID 35731096 Get It

Mortality after multivessel revascularisation involving the proximal left anterior descending artery
Ono, Masafumi , Hara, Hironori , Gao, Chao , Kawashima, Hideyuki , Wang, Rutao , O’Leary, Neil , Mack, Michael J. , Holmes, David R. , Morice, Marie‐Claude, Head, Stuart J., Davierwala, Piroze , Mohr, Friedrich W., Garg, Scot , Onuma, Yoshinobu , Bochenek, Andrzej , Escaned, Javier , Curzen, Nick , Garg, Scot , Serruys, Patrick W , Curzen, Nick , Onuma, Yoshinobu , Escaned, Javier , Wykrzykowska, Joanna J. , Piek, Jan J , Kappetein, A. Pieter , Noack, Thilo , Serruys, Patrick W.

Mayo Clinic

Heart | June 22, 2022 | Volume: 108 | Issue: 22 | Pages: 1784-1791

10.1136/heartjnl-2022-320934 | PMID 35732441 Get It

Objective We sought to investigate whether long-term clinical outcomes differ following percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in patients with three-vessel disease (3VD) and lesions in the proximal left anterior descending artery (P-LAD). Methods This post-hoc analysis of the Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) Extended Survival study included patients with 3VD who were classified according to the presence or absence of lesions located in the P-LAD. Ten-year all-cause death and 5-year major adverse cardiac or cerebrovascular events (MACCE) were assessed. Results Among 1088 patients with 3VD, 559 (51.4%) had involvement of P-LAD and their 10-year mortality was numerically higher following PCI versus CABG (28.9% vs 21.9%; HR: 1.39, 95% CI 0.99 to 1.95). Although patients without P-LAD lesions had significantly higher 10-year mortality following PCI compared with CABG, there was no evidence of a treatment-by-subgroup interaction (28.8% vs 20.2%; HR: 1.47, 95% CI 1.03 to 2.09, pinteraction=0.837). The incidence of MACCE at 5 years was significantly higher with PCI than CABG, irrespective of involvement of P-LAD (with P-LAD: HR: 1.86, 95% CI 1.36 to 2.55; without P-LAD: HR: 1.54, 95% CI 1.11 to 2.12; pinteraction=0.408). Individualised assessment using the SYNTAX Score II 2020 established that a quarter of patients with P-LAD lesions had significantly higher mortality with PCI than CABG, whereas in the remaining three-quarters CABG had similar mortality. Conclusions Among patients with 3VD, the presence or absence of a P-LAD lesion was not associated with any treatment effect on long-term outcomes following PCI or CABG. Trial registration number SYNTAXES: NCT03417050; SYNTAX: NCT00114972.
Bronchobiliary Fistula Management With Bronchoscopic Occlusive Stenting and Fibrin Glue Instillation
Lee‐Mateus, Alejandra Yu , Garcia‐Saucedo, Juan C. , Gómez, Victoria , Fernández-Bussy, Sebastián , Yu Lee-Mateus, Alejandra , Abia‐Trujillo, David , Kröner, Paul T.

Mayo Clinic

Journal of Bronchology & Interventional Pulmonology | June 22, 2022 | Volume: 29 | Issue: 3 | Pages: e49-e51

10.1097/lbr.0000000000000812 | PMID 35730787 Get It

Optimising transitions of care for acute kidney injury survivors: protocol for a mixed-methods study of nephrologist and primary care provider recommendations
May, Heather P. , Krauter, Abby K, Finnie, Dawn M., McCoy, Rozalina G. , Frazee, Erin N. , Personett, Heather A. , McCoy, Rozalina Grubina , Kashani, Kianoush , Griffin, Joan M.

Mayo Clinic

BMJ Open | June 22, 2022 | Volume: 12 | Issue: 6 | Pages: e058613

10.1136/bmjopen-2021-058613 | PMID 35732395 Get It

Introduction Acute kidney injury (AKI) affects nearly 20% of all hospitalised patients and is associated with poor outcomes. Long-term complications can be partially attributed to gaps in kidney-focused care and education during transitions. Building capacity across the healthcare spectrum by engaging a broad network of multidisciplinary providers to facilitate optimal follow-up care represents an important mechanism to address this existing care gap. Key participants include nephrologists and primary care providers and in-depth study of each specialty’s approach to post-AKI care is essential to optimise care processes and healthcare delivery for AKI survivors. Methods and analysis This explanatory sequential mixed-methods study uses survey and interview methodology to assess nephrologist and primary care provider recommendations for post-AKI care, including KAMPS (kidney function assessment, awareness and education, medication review, blood pressure monitoring and sick day education) elements of follow-up, the role of multispecialty collaboration, and views on care process-specific and patient-specific factors influencing healthcare delivery. Nephrologists and primary care providers will be surveyed to assess recommendations and clinical decision-making in the context of post-AKI care. Descriptive statistics and the Pearson’s χ 2 or Fisher’s exact test will be used to compare results between groups. This will be followed by semistructured interviews to gather rich, qualitative data that explains and/or connects results from the quantitative survey. Both deductive analysis and inductive analysis will occur to identify and compare themes. Ethics and dissemination This study has been reviewed and deemed exempt by the Institutional Review Board at Mayo Clinic (IRB 20–0 08 793). The study was deemed exempt due to the sole use of survey and interview methodology. Results will be disseminated in presentations and manuscript form through peer-reviewed publication.
U.S. cities will not meet blood product resuscitation standards during major mass casualty incidents: Results of a THOR‐AABB working party prospective analysis
Cannon, Jeremy W. , Igra, Noah M, Borge, P. Dayand , Cap, Andrew P., Doughty, Heidi , Geng, Zhi , Guzmán, Jessica, Ness, Paul M., Jenkins, Donald H. , Rajbhandary, Srijana , Schmulevich, Daniela , Stubbs, James R. , Yazer, Mark H. , Spinella, Philip C. , Devine, Dana V , Rajbhandary, Srijana , Stubbs, James R , Yazer, Mark H , Spinella, Philip C , Cap, Andrew P., Devine, Dana V. , Geng, Zhi, Wiebe, Douglas J.

Mayo Clinic

Transfusion | June 22, 2022 | Volume: 62 | Issue: S1 | Pages: No page available

10.1111/trf.16960 | PMID 35730720 Get It

AbstractBackgroundMass casualty incidents (MCIs) create an immediate surge in blood product demand. We hypothesize local inventories in major U.S. cities would not meet this demand.Study Design and MethodsA simulated blast in a large crowd estimated casualty numbers. Ideal resuscitation was defined as equal amounts of red blood cells (RBCs), plasma, platelets, and cryoprecipitate. Inventory was prospectively collected from six major U.S. cities at six time points between January and July 2019. City‐wide blood inventories were classified as READY (>1 U/injured survivor), DEFICIENT (<10 U/severely injured survivor), or RISK (between READY and DEFICIENT), before and after resupply from local distribution centers (DC), and features of DEFICIENT cities were identified.ResultsThe simulated blast resulted in 2218 injured survivors including 95 with severe injuries. Balanced resuscitation would require between 950 and 2218 units each RBC, plasma, platelets and cryoprecipitate. Inventories in 88 hospitals/health systems and 10 DCs were assessed. Of 36 city‐wide surveys, RISK inventories included RBCs (n = 16; 44%), plasma (n = 24; 67%), platelets (n = 6; 17%), and cryoprecipitate (n = 22; 61%) while DEFICIENT inventories included platelets (n = 30; 83%) and cryoprecipitate (n = 12; 33%). Resupply shifted most RBC and plasma inventories to READY, but some platelet and cryoprecipitate inventories remained at RISK (n = 24; 67% and n = 12; 33%, respectively) or even DEFICIENT (n = 11; 31% and n = 6; 17%, respectively). Cities with DEFICIENT inventories were smaller (p <.001) with fewer blood products per trauma bed (p <.001).DiscussionIn this simulated blast event, blood product demand exceeded local supply in some major U.S. cities. Options for closing this gap should be explored to optimize resuscitation during MCIs.